Novavax Inc NVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
179.22quote price arrow up+4.38 (+2.51%)
Volume
59,751
Close
174.84quote price arrow up+16.74 (+10.59%)
Volume
5,692,775
52 week range
6.77 - 331.68

...

Loading . . .

KEY STATS

  • Open166.59
  • Day High175.89
  • Day Low149.12
  • Prev Close158.10
  • 52 Week High331.68
  • 52 Week High Date02/09/21
  • 52 Week Low6.77
  • 52 Week Low Date03/16/20
  • Market Cap12.914B
  • Shares Out73.86M
  • 10 Day Average Volume3.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.65
  • 1 Year % Change1,300.96

RATIOS/PROFITABILITY

  • EPS (TTM)-6.79
  • P/E (TTM)-25.77
  • Fwd P/E (NTM)16.95
  • EBITDA (MRQ)-415.734M
  • ROE (MRQ)-189.60%
  • Revenue (MRQ)475.60M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-87.94%
  • Debt To Equity (MRQ)74.61%

EVENTS

  • Earnings Date05/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Related Video

VIDEO5:1805:18
Novavax CEO says Covid-19 shot could be cleared for the U.S. by May

Profile

MORE
Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates...
James Young Ph.D.
Chairman
Stanley Erck
President
Rick Crowley
Chief Operating Officer
Gregory Covino
Chief Financial Officer
Ben Machielse
Executive Vice President
Address
21 Firstfield Rd
Gaithersburg, MD
20878-1757
United States